These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 20154585)
1. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Sangoi AR; McKenney JK Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585 [TBL] [Abstract][Full Text] [Related]
2. [Pheochromocytoma--pathohistologic and immunohistochemical aspects]. Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991 [TBL] [Abstract][Full Text] [Related]
3. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065 [TBL] [Abstract][Full Text] [Related]
4. The alpha subunit of inhibin in adrenal cortical neoplasia. Pelkey TJ; Frierson HF; Mills SE; Stoler MH Mod Pathol; 1998 Jun; 11(6):516-24. PubMed ID: 9647588 [TBL] [Abstract][Full Text] [Related]
5. High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Saeger W; Fassnacht M; Chita R; Prager G; Nies C; Lorenz K; Bärlehner E; Simon D; Niederle B; Beuschlein F; Allolio B; Reincke M Hum Pathol; 2003 Feb; 34(2):180-6. PubMed ID: 12612887 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases. Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444 [TBL] [Abstract][Full Text] [Related]
7. BCL-2 expression and inhibin-A in adrenal neoplasms: a comparative study. Fogt F; Zimmerman RL; Mulligan N; Vortmeyer AO; Poremba C; Harris CA; Alsaigh N; Tomaszewski JE; Nikulasson ST Int J Mol Med; 1999 Mar; 3(3):271-4. PubMed ID: 10028050 [TBL] [Abstract][Full Text] [Related]
8. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281 [TBL] [Abstract][Full Text] [Related]
9. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry. Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865 [TBL] [Abstract][Full Text] [Related]
10. Pathology of adrenal neoplasms. Saeger W Minerva Endocrinol; 1995 Mar; 20(1):1-8. PubMed ID: 7651277 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. Zhao C; Bratthauer GL; Barner R; Vang R Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194 [TBL] [Abstract][Full Text] [Related]
12. Ultrastructural findings in adrenal cortical adenomas clinically mimicking pheochromocytoma: a comparison with other adrenal tumors and tissue preparation techniques. Perrino CM; Prall DN; Calomeni EP; Nadasdy T; Zynger DL Ultrastruct Pathol; 2012 Oct; 36(5):287-93. PubMed ID: 23025647 [TBL] [Abstract][Full Text] [Related]
13. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma. Browning L; Bailey D; Parker A J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332 [TBL] [Abstract][Full Text] [Related]
14. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas]. Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases. Zhao C; Bratthauer GL; Barner R; Vang R Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions. Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464 [TBL] [Abstract][Full Text] [Related]
17. Comparison of immunomarkers for the identification of adrenocortical cells in cytology specimens. Jalali M; Krishnamurthy S Diagn Cytopathol; 2005 Aug; 33(2):78-82. PubMed ID: 16007649 [TBL] [Abstract][Full Text] [Related]
18. A review of clinicopathologic features of pheochromocytomas in Hong Kong Chinese. Lam KY; Chan AC; Wong WM; Lam KS Eur J Surg Oncol; 1993 Oct; 19(5):421-7. PubMed ID: 8405477 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients. Elmoneim HM; Samaka RM; Ali H Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854 [TBL] [Abstract][Full Text] [Related]
20. [The expression of A103 and inhibin alpha in adrenocortical adenoma by high-throughput tissue microarray techniques]. Zhang H; Liu W; Wang X; Li G; Guo J; Li F; Liao D Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):424-6. PubMed ID: 12910679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]